Page 8 - While Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share: Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 48.7%. But there is no question some big-name stocks performed better than others along the way. BioNTech’s Big Run: One company that has been a home-run investment in the last year has been biotech stock BioNTech SE - ADR (NASDAQ: BNTX). BioNTech’s claim to fame in the past year has been its COVID-19 vaccine partnership with pharma giant Pfizer Inc. (NYSE: PFE). While Pfizer’s shares have lagged in the past y...

Government spends $24m on COVID jab ads By Shannon Jenkins Wednesday January 27, 2021 Australians can expect to see advertisements calling on them to get a COVID-19 vaccine from Wednesday, with the federal government launching its $23.9 million public information campaign across television, radio, social media and other platforms. The campaign will inform Australians of vaccine-related details, including their safety and effectiveness, and where to get the jab, according to health minister Greg Hunt. “The information in this campaign, based on expert and independent medical advice, will h...

What to Know About Johnson & Johnson’s Single-Dose COVID-19 Vaccine Prevention 3/12/2021 Korin Miller Johnson & Johnson’s single-dose COVID-19 vaccine has been authorized for emergency use by the U.S. Food and Drug Administration. On March 10, President Joe Biden announced his intent to purchase an additional 100 million doses of the Johnson & Johnson vaccine. The Johnson & Johnson vaccine was 85% effective at preventing severe or critical forms of COVID-19 28 days after vaccination and 100% effective at preventing COVID-related deaths in the company’s phase 3 clinica...

The world's top coronavirus vaccine drugmaker has been underperforming. I think 2021 will change that.

POLITICO U.S. could get additional Pfizer vaccine doses by summer Officials “are engaged in active negotiations” with Pfizer to boost the U.S. supply, HHS Secretary Alex Azar told reporters Wednesday morning. Dr. Michelle Chester draws the Pfizer-BioNTech COVID-19 vaccine into a syringe at Long Island Jewish Medical Center, Monday, Dec. 14, 2020, in the Queens borough of New York. (AP Photo/Mark Lennihan, Pool) | Mark Lennihan, Pool/AP Photo Updated: Link Copied The United States is negotiating with Pfizer to supply more coronavirus vaccines by midyear, despite the company’s earlier wa...